The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans
Author(s) -
Finlin BS,
Hasiyet Memetimin,
Zhu B,
A.L. Confides,
Vekaria HJ,
El Khouli RH,
Johnson ZR,
Westgate PM,
Jiajun Chen,
Morris Aj,
Sullivan Pg,
Dupont-Versteegden EE,
Kern Pa
Publication year - 2020
Publication title -
yearbook of pediatric endocrinology
Language(s) - English
Resource type - Journals
eISSN - 1662-4009
pISSN - 1662-3991
DOI - 10.1530/ey.17.11.10
Subject(s) - mirabegron , agonist , endocrinology , medicine , glucose homeostasis , homeostasis , receptor , adrenergic , pharmacology , diabetes mellitus , insulin resistance , alternative medicine , pathology , overactive bladder
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom